Hammer on THOR

A long non-coding RNA dubbed THOR might have a key role in cancer development and could be a potential drug target, according to a new study from University of Michigan researchers.

Michigan's Arul Chinnaiyan and his colleagues sifted through a compendium of lncRNAs they recently developed using large-scale RNA sequencing. Through this, they uncovered 82 highly conserved lncRNAs, including THOR, as they report in Cell this week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.